Toggle Nav
Close
  • Menu
  • Setting

Anti-SLITRK6 Antibody (Sirtratumab vedotin)

Catalog No.
F1561
Anti-SLITRK6 Antibody (Sirtratumab vedotin)
Grouped product items
SizePriceStock Qty
100ug
Please inquire
Ship with 3-5 days
1mg
Please inquire
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Sirtratumab Vedotin (ASG-15ME) is an antibody-drug conjugate (ADC) consisting of SLTRK6 (SLIT and NTRK-like family, member 6) and the cytotoxic monomethyl auristatin E (MMAE). It delivers a small molecule microtubule disrupting agent, monomethyl auristatin E (MMAE), to tumor cells expressing SLITRK6. Sirtratumab Vedotin has the potential to be used in bladder cancer and metastatic urothelial carcinoma research.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

145 kDa

Shipping

Dry ice

Cas No.

1824663-83-3

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

AGS-15E, AGS15C–SGD-1006

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q9H5Y7

Reactivity

Human

Conjugation

MMAE

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Target

SLITRK6

Note

Please avoid freeze-thaw cycles.